AstraZeneca and Oracle collaborate to test AI in clinical trial recruitment

AstraZeneca and Oracle have partnered to investigate how AI and real-world data can help medical teams recruit eligible clinical trial candidates. The initiative aims to address recruitment hurdles by enabling healthcare providers to spot suitable individuals with ease. Both organisations plan to examine a continuous learning structure that applies data from research to guide patient care. Credit: Oracle. AstraZeneca and Oracle have signed a non-binding agreement to investigate how AI and real-world data can help medical teams recruit eligible candidates for clinical trials. The initiative aims to address participant recruitment hurdles by enabling healthcare providers to spot suitable individuals earlier…

Source: Clinical Trials Arena